Clinical trial
Use of a Microsampling Kit for the Therapeutic Drug Monitoring (TDM) of Caffeine in Premature Newborns
NCT07779915 is registered in ClinicalTrials.gov with University Hospital, Limoges as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of a Microsampling Kit for the Therapeutic Drug Monitoring (TDM) of Caffeine in Premature Newborns
- Lead sponsor
- University Hospital, Limoges
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- October 1, 2026
- Completion date
- December 24, 2027
- Enrollment
- 40 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
apnea of prematurity